Publicaciones en colaboración con investigadores/as de Centre Hospitalier Regional et Universitaire de Lille (9)

2023

  1. Artificial intelligence-based pathology as a biomarker of sensitivity to atezolizumab-bevacizumab in patients with hepatocellular carcinoma: a multicentre retrospective study

    The Lancet. Oncology, Vol. 24, Núm. 12, pp. 1411-1422

2022

  1. Correction to: The MELD Score Is Superior to the Maddrey Discriminant Function Score to Predict Short-Term Mortality in Alcohol-Associated Hepatitis: A Global Study

    The American journal of gastroenterology, Vol. 117, Núm. 5, pp. 818

  2. The MELD Score Is Superior to the Maddrey Discriminant Function Score to Predict Short-Term Mortality in Alcohol-Associated Hepatitis: A Global Study

    American Journal of Gastroenterology, Vol. 117, Núm. 2, pp. 301-310

2021

  1. Loss of hepatocyte identity following aberrant YAP activation: A key mechanism in alcoholic hepatitis

    Journal of Hepatology, Vol. 75, Núm. 4, pp. 912-923

  2. Serum transferrin as a biomarker of hepatocyte nuclear factor 4 alpha activity and hepatocyte function in liver diseases

    BMC Medicine, Vol. 19, Núm. 1

2020

  1. Serum Transferrin Is an Independent Predictor of Mortality in Severe Alcoholic Hepatitis

    American Journal of Gastroenterology, Vol. 115, Núm. 3, pp. 398-405

2019

  1. Correction: Arterial tortuosity syndrome: 40 new families and literature review (Genetics in Medicine, (2018), 20, 10, (1236-1245), 10.1038/gim.2017.253)

    Genetics in Medicine

2018

  1. Arterial tortuosity syndrome: 40 new families and literature review

    Genetics in Medicine, Vol. 20, Núm. 10, pp. 1236-1245

2015

  1. Current preventive strategies and management of Epstein-Barr virus-related post-transplant lymphoproliferative disease in solid organ transplantation in Europe. Results of the ESGICH Questionnaire-based Cross-sectional Survey

    Clinical Microbiology and Infection, Vol. 21, Núm. 6, pp. 604.e1-604.e9